PharmaVentures is a premier transaction advisory firm and a leading international company in partnering, M&A deals and strategic alliances. For over 30 years, PharmaVentures has acted as advisor on over 1,000 deal related projects covering licensing, mergers, acquisitions, divestments, and joint venture activities for companies worldwide. PharmaVentures’ deep bank of specialist experience, deal analytics and network of contacts among innovators and large pharma makes it uniquely placed to support business in all aspects of deal making and strategic planning. PharmaVentures is well known for its deep insight into deal structures and its success for generating partnering interest. PharmaVentures’ services include: • M&A (divestments, mergers, acquisitions, and strategic transactions) • Licensing (in and out licensing) • Fundraising Support • Strategy (commercialisation, deal strategy, due diligence, market entry) • Valuations (licensing, M&A, and fundraising) • Pricing and Market Access PharmaVentures Capital Ltd is a wholly owned subsidiary of PharmaVentures Ltd. All regulated activities are delivered through PharmaVentures Capital Ltd, which is authorised and regulated by the Financial Conduct Authority (741356). For more details, visit https://www.pharmaventures.com
View Top Employees from PharmaVenturesWebsite | http://www.pharmaventures.com |
Revenue | $5 million |
Employees | 42 (42 on RocketReach) |
Founded | 1992 |
Phone | +44 1865 332700 |
Fax | +44 1865 332737 |
Technologies |
JavaScript,
HTML,
PHP
+21 more
(view full list)
|
Industry | Business Consulting and Services, Finance General, Biotechnology, Strategy, Finance, Science and Engineering, Mergers, Acquisitions, Licensing, Joint Ventures, Financing, Brokerage, Evaluation, Valuation, Commercial Intelligence, Due Diligence, Negotiation, Alliance Management, Expert Opinion, Arbitration, Mediation, Litigation, Television |
Web Rank | 5 Million |
Keywords | Pharma Consulting Case Studies, Pharmaventures Oxford, Pharma Ventures, M&A Pharmaceuticals, Pdf Global Big Pharma Partnering Terms And Agreements 2012-2018: Deal Trends, Players And Financials |
Competitors | Challenge Advisory, Extera Partners LLC, Genesis Ireland, Locust Walk, Plexus Ventures LLC |
SIC | SIC Code 621 Companies, SIC Code 62 Companies |
NAICS | NAICS Code 523 Companies, NAICS Code 523110 Companies, NAICS Code 52311 Companies, NAICS Code 52 Companies, NAICS Code 5231 Companies |
Looking for a particular PharmaVentures employee's phone or email?
The PharmaVentures annual revenue was $5 million in 2024.
Fintan Walton is the Chairman and Chief Executive of PharmaVentures.
42 people are employed at PharmaVentures.
The NAICS codes for PharmaVentures are [523, 523110, 52311, 52, 5231].
The SIC codes for PharmaVentures are [621, 62].